As expected, and based on previous metabolic surgical cohorts, circulating biomarkers for both insulin resistance (Haemoglobin A1C, HOMA-IR (homeostatic model assessment of insulin resistance)) and inflammation (C-Reactive Protein (CRP), Interleukin-6 (IL6)) were significantly reduced after metabolic surgery. Here, IL6 is linked to Insulin resistance.